Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sanpu Pharmaceutical, also frequently referred to as Sampu Pharmaceutical, is a leading Chinese pharmaceutical group specializing in the research, development, and manufacturing of Traditional Chinese Medicine (TCM) and natural plant extracts. Headquartered in Xining, Qinghai, the company is particularly renowned for its expertise in high-altitude medicine, leveraging botanical sources from the Qinghai-Tibet Plateau such as Rhodiola crenulata. As a core subsidiary of the Far East Holding Group, Sanpu integrates modern biochemical manufacturing standards with traditional herbal knowledge to produce a diverse portfolio of cardiocerebral vascular drugs, respiratory treatments, and nutraceuticals. Its flagship products, including Rhodiola-based capsules and heart-brain tonics, are widely recognized in the Chinese market for their antioxidant and cardioprotective properties.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sanpu Pharmaceutical.